Purdue Pharma Pleads Guilty. Consulting Firm Advised Rebates for OxyContin Overdoses.

Opioids have killed more than 450,000 people over the past two decades. Last week, as part of a sweeping settlement with the DOJ, Purdue Pharma, controlled by the Sackler family, pleaded guilty to three criminal charges. The bankrupt company admitted it obstructed the DEA by claiming to have a program to keep their drugs off of the black market when there was no plan in place; Purdue acknowledged that it provided the DEA with misleading information to boost its manufacturing quotas, and it pushed doctors to prescribe more of its drugs through various kickback schemes. Officials have said Purdue will also face more than $8-billion in civil and criminal penalties, but the company will likely pay only $225-million under its agreement with federal prosecutors.

According to bankruptcy-court filings, the prestigious consulting firm McKinsey advised in a 2017 presentation to Purdue Pharma, the maker of OxyContin, offering a rebate to distributors whenever a patient overdosed on OxyContin, in part “to counter the emotional messages from mothers with teenagers that overdosed.” The New York Times reported that McKinsey, in a 2017 presentation, estimated that 2,484 customers of drug store chain CVS would overdose or become addicted to opioids in 2019 and it would pay a rebate of $14,810 “per event.” CVS and Anthem said they never received such rebates.

Later, Purdue would ask McKinsey to “dismantle” the marketing plan, with one member of the Sackler family, which owns Purdue, saying they should’ve done so five years prior. Amid the ravages of addiction and death caused by opioids, McKinsey leaders asked Purdue in 2018 whether they needed to prepare for lawsuits by “eliminating all our documents and emails.”

Powerhouse consulting firm McKinsey & Co. promoted a questionable strategy to increase the sales of OxyContin — giving distributors a rebate for every overdose tied to the pills they sold, according to a report.

A trove of documents released in a bankruptcy court case showed McKinsey’s role in advising members of the Sackler family, which owned Oxy maker Purdue Pharma, as opioid deaths mounted, The New York Times reported.

McKinsey, in a 2017 presentation, estimated that 2,484 customers of drug store chain CVS would overdose or become addicted to opioids in 2019 and it would pay a rebate of $14,810 “per event,” The Times reported.

CVS said it did not receive any rebates.

Read full article here…

Additional source:

NY Post: https://nypost.com/2020/11/24/oxycontin-maker-purdue-pharma-pleads-guilty-to-criminal-charges/

Visit our Classified ads.

Check out our Classified ads at the bottom of this page.

Recent stories & commentary


RNA ‘Vaccines’ Are GMO Implants, Not Vaccines

January 19, 2021 David Martin 0

Martin says Moderna describes its product not as a vaccine, but as “gene-therapy technology” in SEC filings. Neither Moderna or Pfizer make any claims about their products creating immunity or preventing transmission. Moderna’s own clinical study says it is “impractical to measure infection.”


Pennsylvania Lt. Gov. John Fetterman Says Freedom of Speech Does not Include the Right to Say the Election was Rigged

Pennsylvania Lieutenant Governor John Fetterman said that “lies” about the legitimacy of the election were not protected under the Constitution. He said, “This idea that saying that Pennsylvania was rigged, or that we were trying to ‘steal the election, that’s a lie.” He said: “That is not protected speech.”


COVID-19 Evidence of Global Fraud

January 18, 2021 In This Together 1

Since no one has ever isolated a sample of this theoretical virus, a precise description of its genetic composition is unknown. Therefore, the fact that authorities have published what they claim is its genome is scientific fraud.


Gavin Newsom Plans To Buy All California Real Estate Foreclosures

January 14, 2021 Matt Aitchison 4

Matt Aitchison says a new law in California, SB 1079, will result in the State entering the real-estate-foreclosed home business, which essentially removes competition from investors, and could ultimately socialize real estate as a whole. He warns that this policy may spread to other Democrat-run sates.


For classified advertising rates and terms, click here. The appearance of ads on this site does not signify endorsement by the publisher. We do not attempt to verify the accuracy of statements made therein or vouch for the integrity of advertisers. However, we will investigate complaints from readers and remove any message we find to be misleading or that promotes anything fraudulent, illegal, or unethical.

Notify of
Inline Feedbacks
View all comments